相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epidemiology and pathogenesis of maternal-fetal transmission of Trypanosoma cruzi and a case for vaccine development against congenital Chagas disease
Lizette Rios et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Pathology and Pathogenesis of Chagas Heart Disease
Kevin M. Bonney et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 14 (2019)
A Review of Curcumin and Its Derivatives as Anticancer Agents
Mhd Anas Tomeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Role of Curcumin in the Modulation of Ageing
Anna Bielak-Zmijewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chagas Disease Treatment and Rational Drug Discovery: A Challenge That Remains
Ana Catarina Cristovao-Silva et al.
FRONTIERS IN PHARMACOLOGY (2019)
Immunity and vaccine development efforts against Trypanosoma cruzi
Lizette E. Rios et al.
ACTA TROPICA (2019)
Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease
Maiara Voltarelli Providello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Paradoxical effects of vitamin C in Chagas disease
J. R. P. T. Castanheira et al.
PARASITOLOGY INTERNATIONAL (2018)
Pentose Phosphate shunt Modulates reactive Oxygen species and nitric Oxide Production controlling Trypanosoma cruzi in Macrophages
Sue-jie Koo et al.
FRONTIERS IN IMMUNOLOGY (2018)
Parasitic interactions among Trypanosoma cruzi, triatomine vectors, domestic animals, and wildlife in Big Bend National Park along the Texas-Mexico border
Rachel Curtis-Robles et al.
ACTA TROPICA (2018)
Anti-parasitic effect of vitamin C alone and in combination with benznidazole against Trypanosoma cruzi
Vanesa Puente et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
The beta-blocker carvedilol and the benznidazole modulate the cardiac immune response in the acute infection induced by Colombian strain of the Trypanosoma cruzi
Aline Luciano Horta et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2018)
Mitochondria as a therapeutic target for common pathologies
Michael P. Murphy et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Pathogenesis of Chronic Chagas Disease: Macrophages, Mitochondria, and Oxidative Stress
Marcos Lopez et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2018)
Antioxidant effects of resveratrol in the cardiovascular system
Ning Xia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
Ajaikumar B. Kunnumakkara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Mitochondrial function as a therapeutic target in heart failure
David A. Brown et al.
NATURE REVIEWS CARDIOLOGY (2017)
Molecular identification and genotyping of Trypanosoma cruzi DNA in autochthonous Chagas disease patients from Texas, USA
Melissa N. Garcia et al.
INFECTION GENETICS AND EVOLUTION (2017)
Nonsteroidal anti-inflammatory is more effective than anti-oxidant therapy in counteracting oxidative/nitrosative stress and heart disease in T. cruzi-infected mice
Romulo D. Novaes et al.
PARASITOLOGY (2017)
Evaluation of antioxidant therapy in experimental Chagas disease
Thais de Mello Tieghi et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2017)
Antioxidant effect of Morus nigra on Chagas disease progression
Michelly Cristina Montenote et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2017)
Epidemiology and Molecular Typing of Trypanosoma cruzi in Naturally-Infected Hound Dogs and Associated Triatomine Vectors in Texas, USA
Rachel Curtis-Robles et al.
PLOS NEGLECTED TROPICAL DISEASES (2017)
Experimental and Clinical Treatment of Chagas Disease: A Review
Policarpo Ademar Sales Junior et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease
Jake Jianjun Wen et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
Effects of astaxanthin in mice acutely infected with Trypanosoma cruzi
Jose Mara Eloy Contreras-Ortiz et al.
PARASITE (2017)
Current drug therapy and pharmaceutical challenges for Chagas disease
Jose Bermudez et al.
ACTA TROPICA (2016)
Impact of the Use of Benznidazole Followed by Antioxidant Supplementation in the Prevalence of Ventricular Arrhythmias in Patients With Chronic Chagas Disease: Pilot Study
Joao Luis Barbosa et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease
Romulo Dias Novaes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Oxidative Stress and Myocarditis
Yuko Tada et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study
Saleh Ayashi et al.
INDIAN JOURNAL OF PHARMACOLOGY (2016)
Multiplicity of effects and health benefits of resveratrol
Lolita Kurgvietiene et al.
MEDICINA-LITHUANIA (2016)
Resveratrol and Cardiovascular Diseases
Dominique Bonnefont-Rousselot
NUTRIENTS (2016)
Resveratrol Reverses Functional Chagas Heart Disease in Mice
Glaucia Vilar-Pereira et al.
PLOS PATHOGENS (2016)
SIRT1-PGC1α-NFκB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease
Xianxiu Wan et al.
PLOS PATHOGENS (2016)
Multiplicity of effects and health benefits of resveratrol
Lolita Kurgvietiene et al.
MEDICINA-LITHUANIA (2016)
Chagas' heart disease: gender differences in myocardial damage assessed by cardiovascular magnetic resonance
Antonildes N. Assuncao et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
Antioxidants in Translational Medicine
Harald H. H. W. Schmidt et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease
Lindsey H. Malik et al.
CLINICAL CARDIOLOGY (2015)
Interleukin-17, oxidative stress, and inflammation: role of melatonin during Trypanosoma cruzi infection
Vania Brazao et al.
JOURNAL OF PINEAL RESEARCH (2015)
Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE
Ricardo Guimaraes Marim et al.
REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2015)
The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process
Vania Cristina Desoti et al.
PLOS ONE (2015)
Mitochondria-targeted antioxidants for treatment of Parkinson's disease: Preclinical and clinical outcomes
Huajun Jin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Alterations of mitochondria in liver but not in heart homogenates after treatment of rats with benznidazole
D. A. Rendon
HUMAN & EXPERIMENTAL TOXICOLOGY (2014)
Resveratrol and Endothelial Nitric Oxide
Ning Xia et al.
MOLECULES (2014)
Astaxanthin: Sources, Extraction, Stability, Biological Activities and Its Commercial Applications-A Review
Ranga Rao Ambati et al.
MARINE DRUGS (2014)
Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
Renata Sesti-Costa et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
Andrea Trochine et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Carvedilol Enhances the Antioxidant Effect of Vitamins E and C in Chronic Chagas Heart Disease
Patricia Budni et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2013)
Desferrioxamine Reduces Oxidative Stress in the Lung Contusion
Umit Nusret Basaran et al.
SCIENTIFIC WORLD JOURNAL (2013)
Innate Immune Responses and Antioxidant/Oxidant Imbalance Are Major Determinants of Human Chagas Disease
Monisha Dhiman et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Carvedilol Attenuates Oxidative Stress in Chronic Chagasic Cardiomyopathy
Patricia Budni et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2012)
Oxidative stress fuels Trypanosoma cruzi infection in mice
Claudia N. Paiva et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Proteome Expression and Carbonylation Changes During Trypanosoma cruzi Infection and Chagas Disease in Rats
Jian-Jun Wen et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Curcumin treatment provides protection against Trypanosoma cruzi infection
Fnu Nagajyothi et al.
PARASITOLOGY RESEARCH (2012)
Defects of mtDNA Replication Impaired Mitochondrial Biogenesis During Trypanosoma cruzi Infection in Human Cardiomyocytes and Chagasic Patients: The Role of Nrf1/2 and Antioxidant Response
Xianxiu Wan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Intraphagosomal Peroxynitrite as a Macrophage-derived Cytotoxin against Internalized Trypanosoma cruzi CONSEQUENCES FOR OXIDATIVE KILLING AND ROLE OF MICROBIAL PEROXIREDOXINS IN INFECTIVITY
Mara Noel Alvarez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Targeting AMPK for cardiac protection: Opportunities and challenges
Maengjo Kim et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease
Monisha Dhiman et al.
JOURNAL OF PATHOLOGY (2011)
Mitochondria and Trypanosomatids: Targets and Drugs
Lianet Monzote Fidalgo et al.
PHARMACEUTICAL RESEARCH (2011)
Would selenium supplementation aid in therapy for Chagas Disease?
Linda A. Jelicks et al.
TRENDS IN PARASITOLOGY (2011)
Mitochondrial Complex III Defects Contribute to Inefficient Respiration and ATP Synthesis in the Myocardium of Trypanosoma cruzi-Infected Mice
Jian-Jun Wen et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Induction of NADPH oxidase activity and reactive oxygen species production by a single Trypanosoma cruzi antigen
Natalia Guinazu et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2010)
Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease
Carine Muniz Ribeiro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Trypanosoma cruzi Induces the Reactive Oxygen Species-PARP-1-RelA Pathway for Up-regulation of Cytokine Expression in Cardiomyocytes
Xueqing Ba et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phenyl-alpha-tert-butyl-nitrone and Benzonidazole Treatment Controlled the Mitochondrial Oxidative Stress and Evolution of Cardiomyopathy in Chronic Chagasic Rats
Jian-Jun Wen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Chagas disease: a new worldwide challenge
Jose Rodrigues Coura et al.
NATURE (2010)
Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease
Amanda Fortes Francisco et al.
REDOX REPORT (2010)
Melatonin: Action as antioxidant and potential applications in human disease and aging
Dominique Bonnefont-Rousselot et al.
TOXICOLOGY (2010)
Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes
Shivali Gupta et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice
Jian-Jun Wen et al.
MICROBES AND INFECTION (2008)
Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease
Leonilda Banki Macao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Oxidative stress in chronic cardiopathy associated with Chagas disease
Tiago Bittencourt de Oliveira et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Antioxidant activity of carvedilol in cardiovascular disease
Paresh Dandona et al.
JOURNAL OF HYPERTENSION (2007)
Phenyl-α-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease
Jian-Jun Wen et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients
Jian-jun Wen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy
E Cunha-Neto et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense
JJ Wen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development
G Vyatkina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy
S Mukherjee et al.
PARASITOLOGY RESEARCH (2003)
Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals
R Pérez-Fuentes et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Melatonin improves deferoxamine antioxidant activity in protecting against lipid peroxidation caused by hydrogen peroxide in rat brain homogenates
S Ortega-Gutiérrez et al.
NEUROSCIENCE LETTERS (2002)
Radical-scavenging and iron-chelating properties of carvedilol, an antihypertensive drug with antioxidative activity
K Oettl et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection
M Saeftel et al.
INFECTION AND IMMUNITY (2001)
Time-dependent oxidative stress caused by benznidazole
RC Pedrosa et al.
REDOX REPORT (2001)
分享论文
